Evidence map›Paper›PMID 24304907›Full record

ReviewSeminars in cancer biology2014

The conundrum of causality in tumor virology: the cases of KSHV and MCV.

Patrick S Moore, Yuan Chang

Abstract readHistorical ArticleReview
In one paragraph

Review in Seminars in cancer biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Risk of Rare Cancers Among Solid Organ Transplant Recipients.Journal of the National Cancer Institute · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Cancer in wildlife: patterns of emergence.Nature reviews. Cancer · 2018
    Review
  14. Review
  15. Article
  16. Tumour virology in the era of high-throughput genomics.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Review
  17. Human oncogenic viruses: nature and discovery.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Article
  18. Article
  19. Common Commensal Cancer Viruses.PLoS pathogens · 2017
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Patrick S MooreCancer Virology Program, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh, PA 15213, United States. Electronic address: psm9@pitt.edu.
Yuan ChangCancer Virology Program, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh, PA 15213, United States. Electronic address: yc70@pitt.edu.

Funding

Role of a New Polyomavirus in Merkel Cell CarcinomaR01CA136806 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MOORE, PATRICK S. · 2009 to 2015
$3.0M
Protein Biomarkers for a New Human Polyomavirus in AIDS-related MalignanciesR01CA136363 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MOORE, PATRICK S. · 2008 to 2015
$2.3M
Transcriptomic and Proteomic Approaches to Discovering Viral Causes for Human HemR01CA170354 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHANG, YUAN · 2012 to 2015
$1.3M
NCI NIH HHS CA136363NCI NIH HHS CA136806NCI NIH HHS CA170354NCI NIH HHS R01 CA136363NCI NIH HHS R01 CA136806NCI NIH HHS R01 CA170354
6 · The paper itself

Abstract

Controversy has plagued tumor virology since the first tumor viruses were described over 100 years ago. Methods to establish cancer causation, such as Koch's postulates, work poorly or not at all for these viruses. Kaposi's sarcoma herpesvirus (KSHV/HHV8) and Merkel cell polyomavirus (MCV) were both found using nucleic acid identification methods but they represent opposite poles in the patterns for tumor virus epidemiology. KSHV is uncommon and has specific risk factors that contribute to infection and subsequent cancers. MCV and Merkel cell carcinoma (MCC), in contrast, is an example in which mutations to our normal viral flora contribute to cancer. Given the near-ubiquity of human MCV infection, establishing cancer causality relies on molecular evidence that does not fit comfortably within traditional infectious disease epidemiological models. These two viruses reveal some of the challenges and opportunities for inferring viral cancer causation in the age of molecular biology.

Indexed as

Herpesvirus 8, HumanHistory, 18th CenturyHistory, 19th CenturyHistory, 20th CenturyHumansMerkel cell polyomavirusNeoplasmsOncogenic VirusesTumor Virus InfectionsCancer virusCarcinogenic mechanismsCausal inferenceCausalityKaposi's sarcoma herpesvirusMerkel cell polyomavirus

Identifiers

PMID24304907
PMCPMC4040341

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.